Why an SBIR grant deposit is a liability before it is revenue

An early-stage biotech we work with received a $275,000 Small Business Innovation Research (SBIR) Phase 1 award in January. The money arrived in the operating account and the previous bookkeeper recorded the full $275,000 as grant income on the same day. The Profit and Loss report (P&L) showed an unusually strong first quarter.

Six months later, at the end of the performance period, the program officer at the National Institutes of Health requested a financial reconciliation. Actual grant expenditures for the period came to $198,000. The remaining $77,000 had to be returned to the agency or carried forward under a no-cost extension. Neither option appeared anywhere in the books. The company had been overstating revenue by $77,000 for six months.

What an SBIR award actually is

An SBIR grant is a contract to perform specific scientific work over a specific period, typically six months for Phase 1 and two years for Phase 2. The funding agency pays in advance so the company has working capital. The company owes the work.

Until the work is performed and the expenditures are documented, the unspent portion of the grant is deferred revenue. Deferred revenue is a liability, not income. It represents an obligation the company has not yet fulfilled.

Recording the full grant deposit as income on day one is the same error as a retailer recording a customer prepayment as revenue before shipping the product. The cash is real. The revenue is not earned yet.

Why grant deposits are commonly recorded as income

Grant funds hit the bank like any other payment. The deposit looks like income. If the bookkeeping system is set to record all inflows as revenue, the grant goes straight to the income account without question.

The deferred revenue account is never set up. Unlike an invoice for a consulting project, a grant award notice does not say “record this as a liability.” The work plan is in a separate document, often managed by the principal investigator rather than the finance team. No one creates the liability account.

The performance period is not tracked in the books. The grant budget may exist in a spreadsheet, but that spreadsheet is rarely connected to the accounting system. The bookkeeper posts expenses as they come in without knowing whether each one is grant-eligible or how much of the award has been spent versus earned.

Investors and auditors read P&L differently than founders do. A P&L showing $275,000 in Q1 income looks like a profitable quarter. An investor reviewing the balance sheet and seeing no deferred revenue liability has no way to know that a significant portion of that income was not actually earned during the period.

What the books should show

Here is how that same $275,000 SBIR Phase 1 award should flow through the books over six months.

Total grant-eligible expenditures over the performance period: $198,000. Grant revenue recognized: $198,000. Deferred revenue remaining at period end: $77,000.

That $77,000 does not disappear. It either gets returned to the funding agency or rolls into a no-cost extension with its own performance period and spending requirements.

Why accurate grant accounting matters

Burn rate reports become unreliable. Investors track how quickly a biotech is consuming cash. If $275,000 of revenue appears in Q1 without a corresponding deferred liability, the company appears to be burning far less than it actually is. When the deferred revenue unwinds, either through a cash return or a revenue reversal, the discrepancy requires explanation at exactly the moment investors are making follow-on decisions.

The balance sheet misrepresents the company’s financial position. Deferred revenue is a real obligation. Grant agencies conduct audits and can request detailed financial reconciliations at any point in the award period. A balance sheet that shows no deferred revenue when $77,000 of unspent funds exist raises questions about the adequacy of financial controls.

The P&L does not match the work performed. The scientific work under an SBIR award is performed over months. Revenue recognized in a single day on the day of deposit does not reflect what the company actually accomplished during any given reporting period.

What proper grant accounting looks like

For Life Sciences clients we work with, every grant award is recorded as a liability on the day the funds arrive. We set up a Deferred Revenue account in QuickBooks and post the full award amount there on receipt.

Each month, we review the grant expenditure report against the approved budget. Expenses that qualify under the grant terms are used to calculate the revenue to release from deferred to earned. A matching journal entry moves that earned amount from Deferred Revenue to Grant Income on the P&L.

At quarter-end, the Deferred Revenue balance on the balance sheet shows exactly how much of the award has not yet been earned. That number is available for any investor, board member, auditor, or program officer who asks.

Best practices for life sciences founders

Specific steps that keep grant accounting accurate from award to closeout:

• Record every grant deposit as a credit to Deferred Revenue, not to income. No exceptions, regardless of award size.
• Create a monthly grant expenditure report that separates grant-eligible costs from general operating expenses.
• Release revenue from Deferred Revenue to Grant Income monthly, matching the amount released to documented expenditures for that month.
• Track the unspent balance against the award total at each quarter-end. If the balance will not be fully spent by the period end, flag it before the deadline so a no-cost extension can be requested in time.
• At award closeout, reconcile the total amount recognized as revenue against total expenditures documented in the financial report submitted to the funding agency.

Three questions worth asking

If you are unsure how grant accounting is being handled in your books today, three questions to start with:

1. When the last grant payment arrived, did it go to a Deferred Revenue liability or directly to a Grant Income account?
2. Does the balance sheet currently show a deferred revenue balance for active awards, and does that balance match the unspent portion of each award?
3. If the grant period ended today, how much would need to be returned or carried forward, and where does that number appear in the books?

If those questions surface any uncertainty, the books may be overstating revenue. The correction is a process change made before the next reporting deadline, not after an audit request arrives.

If you want a second set of eyes, send the award notice and three months of grant expenditure reports. We will review whether the books are tracking earned versus deferred revenue accurately, and what needs to be corrected before closeout.